Slingshot members are tracking this event:

Novartis (NVS) to submit biosimilar Pegfilgrastim for bone marrow stimulation to EU in second half of 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
NVS Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords European Medicines Agency, Bone Marrow Stimulation, Biosimilar, Pegfilgrastim